프레스티지바이오파마
5,480KRWMarket close of 10/20 (Tue)
Down -2.14%-120KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)5,370KRWDown -2.01%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 5,600
- High
- 5,720
- Low
- 5,340
- Day range
- Day range low 5,340 high 5,720, open 5,600, close 5,480, previous close 5,600
- Volume
- 5×10K shares
- 271.12 million KRW 1.58× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
5%5% of the way up from the lowest close in 1 year (252 sessions) · -60.1% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-48.03 million KRWOperating income over the last four quarters -48.03 million KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move-2.14%usual range
- Trading value1.6×usual range
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q4 2025
- Operating income-6.38 million KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
This quarter is derived: annual results minus Q1–Q3.
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-03-03Same sector · 바이오 R&D
Down -2.19%· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -9.6% | Down -3.35% | 51.1B KRW |
| 올릭스 | Close over the last 20 sessions -12.2% | Down -4.03% | 19.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -11.8% | Down -1.93% | 15.1B KRW |
| 리가켐바이오 | Close over the last 20 sessions -15.4% | Down -1.41% | 12.1B KRW |
| 프로티나 | Close over the last 20 sessions +31.8% | Up +7.38% | 10.0B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.